Literature DB >> 16044003

CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

Yea-Lih Lin1, Pierre Portales, Michel Segondy, Vincent Baillat, Corinne Merle de Boever, Vincent Le Moing, Brigitte Réant, Brigitte Montes, Jacques Clot, Jacques Reynes, Pierre Corbeau.   

Abstract

The factors that determine the emergence of X4 isolates in some HIV-1-infected subjects are unknown. As the level of expression of CXCR4 could favor an R5 to X4 switch, quantitative flow cytometry was used to measure CXCR4 density on CD4 T cells in 200 HIV-1-positive adults, and this was compared with CD4 counts, interleukin-7 (IL-7), and RANTES (regulated on activation, normal T expressed and secreted) plasma levels and the R5/X4 virus phenotype. CD4 T-cell surface CXCR4 densities were increased in infected subjects and inversely correlated with CD4 T-cell count (r=-0.548, P<0.001). Yet, in vitro infection with either R5 or X4 strains and in vivo increases in viral load following interruption of antiretroviral treatment did not induce CXCR4 overexpression. The plasma levels of IL-7 and RANTES, 2 cytokines able to induce CXCR4 expression, did not correlate with CXCR4 density. Finally, higher CXCR4 densities were observed in patients harboring X4 strains (3300, 95% CI 2431-4169 CXCR4 molecules per cell) than in patients harboring only R5 strains (2406, 95% CI 2135-2677, P=0.027). These data suggest that CXCR4 overexpression during the course of the disease in some patients could favor the emergence of X4 strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044003

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

Review 1.  New players in cytokine control of HIV infection.

Authors:  Massimo Alfano; Andrea Crotti; Elisa Vicenzi; Guido Poli
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

2.  Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors.

Authors:  Ezequiel Ruiz-Mateos; Alejandro González-Serna; Miguel Genebat; Kawthar Machmach; Francesc Vidal; Angeles Muñoz-Fernández; Sara Ferrando-Martinez; Manuel Leal
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

Review 3.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

4.  Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection.

Authors:  Ariel D Weinberger; Alan S Perelson; Ruy M Ribeiro; Leor S Weinberger
Journal:  PLoS Comput Biol       Date:  2009-08-14       Impact factor: 4.475

5.  Dectin-1/TLR2 and NOD2 agonists render dendritic cells susceptible to infection by X4-using HIV-1 and promote cis-infection of CD4(+) T cells.

Authors:  Sandra C Côté; Audrey Plante; Mélanie R Tardif; Michel J Tremblay
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.